Type 2 Diabetes

OZEMPIC, a GLP-1 receptor agonist, was tested in 2-year cardiovascular outcome trials.

Alex Azar's nomination for secretary of Health and Human Services has been met with controversy due to his ties to the pharmaceutical industry.

Fetuses of obese mothers have higher weight, larger head circumferences and some longer bones, according to a new study.

Combining ACE inhibitors with a statin was unsuccessful to change albumin-to-creatinine ratio in adolescent patients with T1D.

Stay updated on the biggest headlines with MDNN from November 10, 2017.

Use of the Lark AI Health Coach resulted in a mean weight loss of 2.38% of baseline weight.

Rivaroxaban is the only Factor Xa inhibitor demonstrating superior efficacy in reducing recurrent VTE after initial treatment.

The FDA advisory committee voted 16-0 in favor semaglutide's approval.

What about those patients who fall into the "gray zone"?

The Certified Nurse Practicioner from the Henry Ford Medical Center also weighs in the best advice to avoid cardiovascular disease.

Gregg Fonarow, MD; David Aguilar, MD; Rob Mentz, MD; and James Januzzi, MD, discuss the unexpected and exciting use of SGLT-2 inhibitors to treat heart failure.

Rob Mentz, MD, of Duke University Medical School, discusses the CANVAS trial and the pursuit of using SGLT-2 inhibitors to treat heart failure.

The drug, produced by Sanofi, was granted approval based on the physiochemical, non-clinical, and clinical similarity to another, already approved insulin lispro injection.

In just 9 days of limited fructose consumption, both liver fat concentration and de novo lipogensis decreased.

Liraglutide showed a 13% reduction in major adverse cardiovascular events, reduced cardiovascular morbidity by 22%, and any morbidity by 15%.

Sulforaphane has been found to lower glucose production and improve control in T2D patients.

A new study suggests type 2 diabetes progresses, or perhaps begins, in a manner similar to prion diseases like mad cow disease.

Results of a small systematic review identify a vulnerable ethnic group members of which may be patients in your practice.

A meta-analysis of 9 studies found that water-based exercise is an equal alternative for type 2 diabetics.

Despite the results of a large-scale trial, some experts questioned the use of beta-blockers for patients that suffered from heart failure and simultaneous AFib when in the presence of beta-adverse medications, like amiodarone.

A study from the University of Warwick revealed a link between levels of gut hormone FGF-19 and diabetic remission in bariatric surgical patients.

Hybrid closed loop technology for CGM is available today; a contact lens may do the same thing soon. A look at 5 new diabetes tools.

Can we borrow elements of gaming apps to help patients better engage with their diabetes?